Xetrios Therapeutics Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Xetrios Therapeutics General Information


Provider of research and development services to engineering and life sciences industries. The company provides research and development services related to human therapeutics targeting the TAM RTK family.

Contact Information

Ownership Status
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Commercial Services
Other Industries
Other Healthcare Services
Corporate Office
  • 4704 Niagara Avenue
  • San Diego, CA 92107
  • United States
+1 (858) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Xetrios Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Xetrios Therapeutics‘s full profile, request access.

Request a free trial

Xetrios Therapeutics Patents

Xetrios Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-2877211-A1 Regulating the interaction between tam ligands and lipid membranes with exposed phosphatidylserine Inactive 25-Jul-2012 000000000
EP-2877211-A4 Regulating the interaction between tam ligands and lipid membranes with exposed phosphatidylserine Inactive 25-Jul-2012 000000000 0

Xetrios Therapeutics FAQs

  • When was Xetrios Therapeutics founded?

    Xetrios Therapeutics was founded in 2009.

  • Who is the founder of Xetrios Therapeutics?

    Carla Rothlin Ph.D, Greg Lemke Ph.D, and Lawrence Fritz Ph.D are the founders of Xetrios Therapeutics.

  • Where is Xetrios Therapeutics headquartered?

    Xetrios Therapeutics is headquartered in San Diego, CA.

  • What industry is Xetrios Therapeutics in?

    Xetrios Therapeutics’s primary industry is Other Commercial Services.

  • Is Xetrios Therapeutics a private or public company?

    Xetrios Therapeutics is a Private company.

  • What is Xetrios Therapeutics’s current revenue?

    The current revenue for Xetrios Therapeutics is 000000.

  • When was Xetrios Therapeutics acquired?

    Xetrios Therapeutics was acquired on 07-Aug-2014.

  • Who acquired Xetrios Therapeutics?

    Xetrios Therapeutics was acquired by Kolltan Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »